Congenital cytomegalovirus infection

Current Problems in Pediatric and Adolescent Health Care

Volumn 33, Issue 3, 2003, Pages 70-93

  Jones, Cheryl A ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CIDOFOVIR; CYTOMEGALOVIRUS VACCINE; FOSCARNET; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN M; SYNAPTOTAGMIN; VALGANCICLOVIR;

AMNIOCENTESIS; CENTRAL NERVOUS SYSTEM DISEASE; CLINICAL FEATURE; CYTOMEGALOVIRUS INFECTION; DEVELOPING COUNTRY; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DISEASE TRANSMISSION; ECHOGRAPHY; FETUS BLOOD SAMPLING; HEARING IMPAIRMENT; HEMATOLOGIC DISEASE; HUMAN; IMMUNOMODULATION; INCIDENCE; INFANT; LIVER DISEASE; LYMPHOCYTE TRANSFER; MATERNAL CARE; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEWBORN DEATH; NEWBORN SCREENING; PARENT COUNSELING; PATHOGENESIS; PERCEPTION DEAFNESS; PLACENTAL TRANSFER; POLYMERASE CHAIN REACTION; PREDICTION; PRENATAL DIAGNOSIS; PREVALENCE; PROGNOSIS; REVIEW; RISK FACTOR; SENSITIVITY ANALYSIS; SENSORY DYSFUNCTION; SEROCONVERSION; SEROLOGY; T LYMPHOCYTE; VIROLOGY; VIRUS CULTURE; VIRUS IMMUNITY; VISUAL DISORDER;

EID: 0037346519     PISSN: 15385442     EISSN: None     Source Type: Journal    
DOI: 10.1067/mps.2003.3     Document Type: Review

References (200)

1. Istas AS, Demmler GJ, Dobbins JG, et al. Surveillance for congenital cytomegalovirus disease: a report from the National Congenital Cytomegalovirus Disease Registry. Clin Infect Dis 1995;20:665-70.
2. Fowler KB, McCollister FP, Dahle AJ, et al. Progressive and fluctuating sensorineural hearing loss in children with asymptomatic congenital cytomegalovirus infection. J Pediatr 1997;130:624-30.
3. Pultoo A, Jankee H, Meetoo G, et al. Detection of cytomegalovirus in urine of hearing-impaired and mentally retarded children by PCR and cell culture. J Commun Dis 2000;32: 101-8.
4. Fowler KB, Pass RF. Cytomegalovirus infection as a cause of hearing loss among children. Am J Public Health 1995; 85:734-5.
5. Hicks T, Fowler K, Richardson M, et al. Congenital cytomegalovirus infection and neonatal auditory screening. J Pediatr 1993;123:779-82.
6. Dereymaeker AM, Fryns JP, Ars B, et al. On the etiology of hearing loss in a population of 155 institutionalized children. Acta Otorhinolaryngol Belg 1991;45:283-91.
7. Griffiths PD, Baboonian C. A prospective study of primary cytomegalovirus infection during pregnancy: final report. Br J Obstet Gynaecol 1984:91307-15.
8. Ahlfors K, Ivarsson SA, Harris S. Report on a long-term study of maternal and congenital cytomegalovirus infection in Sweden: review of prospective studies available in the literature. Scand J Infect Dis 1999;31:443-57.
9. Alford CA, Britt WJ. Cytomegalovirus. In: Roizman B, Whitley RJ, Lopez C, editors. The Human Herpesviruses. 3rd edition. New York: Raven Press; 1993. p. 227-53.
10. Weller TH, Hanshaw JB, Craig JM, et al. Isolation of intranuclear inclusion producing agents from infants with illnesses resembling cytomegalic inclusion disease. Proc Soc Exp Biol (NY) 1957;94:4-12.
11. Mockarski ES Jr. Cytomegalovirus Biology. In: Roizman B, Whitley RJ, Lopez C, editors. The Human Herpesviruses. 3rd edition. New York: Raven Press; 1993. p. 173-226.
12. Bale JF Jr, Petheram. SJ, Robertson M, et al. Human cytomegalovirus a sequence and UL144 variability in strains from infected children. J Med Virol 2001;65:90-6.
13. Bale JF Jr, Murph JR, Demmler GJ, et al. Intrauterine cytomegalovirus infection and glycoprotein B genotypes. J Infect Dis 2000;182:933-6.
14. Barbi M, Binda S, Caroppo S, et al. CMV gB genotypes and outcome of vertical transmission: study on dried blood spots of congenitally infected babies. J Clin Virol 2001;2:75-9.
15. Trincado DE, Scott GM, White PA, et al. Human cytomegalovirus strains associated with congenital and perinatal infections. J Med Virol 2000;61:481-7.
16. Lukacsi A, Tarodi B, Endreffy E, et al. Human cytomegalovirus gB genotype 1 is dominant in congenital infections in South Hungary. J Med Virol 2001;65:537-42.
17. Mocarski ES Jr. Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol 2002;10:332-9.
18. Hahn G, Jores R, Mocarski ES. Cytomegalovirus remains latent in a common precursor of dendritic and myeloid cells. Proc Natl Acad Sci U S A 1998;31:95 3937-42.
19. Soderberg-Naucler C, Fish KN, et al. Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 1997;91:119-26.
20. Waldman WJ, Knight DA, Huang EH, et al. Bidirectional transmission of infectious cytomegalovirus between monocytes and vascular endothelial cells: an in vitro model. J Infect Dis 1995;171:263-72.
21. Doerr HW, Rentschler M, Scheifler G. Serologic detection of active infections with human herpes viruses (CMV, EBV, HSV, VZV): diagnostic potential of IgA class and IgG subclass-specific antibodies. Infection 1987;15:93-8.
22. Pass RF, Stagno S, Dworsky ME, et al. Excretion of cytomegalovirus in mothers: observations after delivery of congenitally infected and normal infants. J Infect Dis 1982; 146:1-6.
23. Cox F, Hughes WT. Fecal excretion of cytomegalovirus in disseminated cytomegalic inclusion disease. J Infect Dis 1974;129:732-6.
24. Pass RF, Little EA, Stagno S, et al. Young children as a probable source of maternal and congenital cytomegalovirus infection. N Engl J Med 1987;316:1366-70.
25. Dworsky ME, Welch K, Cassady G, et al. Occupational risk for primary cytomegalovirus infection among pediatric health-care workers. N Engl J Med 1983;309:950-3.
26. Fisher S, Genbacev O, Maidji E, et al. Human cytomegalovirus infection of placental cytotrophoblasts in vitro and in utero: implications for transmission and pathogenesis. J Virol 2000;74:6808-20.
27. Griffith BP, McCormick SR, Fong CK, et al. The placenta as a site of cytomegalovirus infection in guinea pigs. J Virol 1985;55:402-9.
28. Kleinman D, Sarov I, Insler V. Infection of endometrial cells with human cytomegalovirus. Gynecol Obstet Invest 1984; 17:89-95.
29. Mostoufi-zadeh M, Driscoll SG, Biano SA, et al. Placental evidence of cytomegalovirus infection of the fetus and neonate. Arch Pathol Lab Med 1984;108:403-6.
30. Bissinger AL, Sinzger C, Kaiserling E, et al. Human cytomegalovirus as a direct pathogen: correlation of multiorgan involvement and cell distribution with clinical and pathological findings in a case of congenital inclusion disease. J Med Virol 2002;67:200-6.
31. Koedood M, Fichtel A, Meier P, et al. Human cytomegalovirus (HCMV) immediate-early enhancer/promoter specificity during embryogenesis defines target tissues of congenital HCMV infection. J Virol 1995;69:2194-207.
32. Bale JF Jr, O'Neil ME, Hart MN, et al. Human cytomegalovirus nucleic acids in tissues from congenitally infected infants. Pediatr Neurol 1989;5:216-20.
33. Harrison CJ, Caruso N. Correlation of maternal and pup NK-like activity and TNF responses against cytomegalovirus to pregnancy outcome in inbred guinea pigs. J Med Virol 2000;60:230-6.
34. Keithley EM, Woolf NK, Harris JP. Development of morphological and physiological changes in the cochlea induced by cytomegalovirus. Laryngoscope 1989;99:409-414.
35. Huygen PL, Admiraal RJ. Audiovestibular sequelae of congenital cytomegalovirus infection in 3 children presumably representing 3 symptomatically different types of delayed endolymphatic hydrops. Int J Pediatr Otorhinolaryngol 1996; 35:143-54.
36. Rarey KE, Davis LE. Temporal bone histopathology 14 years after cytomegalic inclusion disease: a case study. Laryngoscope 1993;103:904-9.
37. Lee SH, Girard S, Macina D, et al. Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat Genet 2001;28:42-5.
38. Gehrz RC, Rutzick SR. Cytomegalovirus (CMV)-specific lysis of CMV-infected target cells can be mediated by both NK-like and virus-specific cytotoxic T lymphocytes. Clin Exp Immunol 1985;61:80-9.
39. Boppana SB, Britt WJ. Antiviral antibody responses and intrauterine transmission after primary maternal cytomegalovirus infection. J Infect Dis 1995;171:1115-21.
40. Fernando S, Pearce JM, Booth JC. Lymphocyte responses and virus excretion as risk factors for intrauterine infection with cytomegalovirus. J Med Virol 1993;41:108-13.
41. Rola-Pleszczynski M, Frenkel LD, Fuccillo DA, et al. Specific impairment of cell-mediated immunity in mothers of infants with congenital infection due to cytomegalovirus. J Infect Dis 1977;135:386-91.
42. Boppana SB, Miller J, Britt WJ. Transplacentally acquired antiviral antibodies and outcome in congenital human cytomegalovirus infection. Viral Immunol 1996;9:211-8.
43. Gerna G, Cereda PM, Cattaneo E, et al. Immunoglobulin G to virus-specific early antigens in congenital, primary, and reactivated human cytomegalovirus infections. Infect Immunol 1978;22:833-41.
44. Pass RF, Stagno S, Britt WJ, et al. Specific cell-mediated immunity and the natural history of congenital infection with cytomegalovirus. J Infect Dis 1983;148:953-61.
45. Reynolds DW, Stagno S, Herrman KL, et al. Antibody response to live virus vaccines in congenital and neonatal cytomegalovirus infections. J Pediatr 1978;92:738-42.
46. Hayward AR, Herberger MJ, Groothuis J, et al. Specific immunity after congenital or neonatal infection with cytomegalovirus or herpes simplex virus. J Immunol 1984;133: 2469-73.
47. Starr SE, Tolpin MD, Friedman HM, et al. Impaired cellular immunity to cytomegalovirus in congenitally infected children and their mothers. J Infect Dis 1979;140:500-5.
48. Reynolds DW, Dean PH, Pass RF, et al. Specific cell-mediated immunity in children with congenital and neonatal cytomegalovirus infection and their mothers. J Infect Dis 1979;140:493-9.
49. Gehrz RC, Marker SC, Balfour HH Jr. Specific cell-mediated immune defect in congenital cytomegalovirus infection. Lancet 1979;1:811-2.
50. Gehrz RC, Linner KM, Christianson WR, et al. Cytomegalovirus infection in infancy: virological and immunological studies. Clin Exp Immunol 1982;47:27-33.
51. Pass RF, Dworsky ME, Whitley RJ, et al. Specific lymphocyte blastogenic responses in children with cytomegalovirus and herpes simplex virus infections acquired early in infancy. Infect Immunol 1981;34:166-70.
52. Okabe M, Chiba S, Tamura T, et al. Longitudinal studies of cytomegalovirus-specific cell-mediated immunity in congenitally infected infants. Infect Immunol 1983;41:128-31.
53. Emodi G, Just M. Impaired interferon response of children with congenital cytomegalovirus disease. Acta Paediatr Scand 1974;63:183-7.
54. Stagno S, Reynolds DW, Huang ES, et al. Congenital cytomegalovirus infection. N Engl J Med 1977;296:1254-8.
55. Yamamoto AY, Mussi-Pinhata MM, Cristina P, et al. Congenital cytomegalovirus infection in preterm and full-term newborn infants from a population with a high seroprevalence rate. Pediatr Infect Dis J 2001;20:188-92.
56. Shen CY, Chang SF, Yang SL, et al. Maternal cytomegalovirus infection and maternal age. J Infect Dis 1994;169: 936-7.
57. Griffiths PD, Baboonian C, Rutter D, et al. Congenital and maternal cytomegalovirus infections in a London population. Br J Obstet Gynaecol 1991;98:135-40.
58. Bos P, Steele D, Alexander J. Prevalence of antibodies to rubella, herpes simplex 2 and cytomegalovirus in pregnant women and in neonates at Ga-Rankuwa. Cent Afr J Med 1995;41:14-7.
59. el-Nawawy A, Soliman AT, el Azzouni O, et al. Maternal and neonatal prevalence of toxoplasma and cytomegalovirus (CMV) antibodies and hepatitis-B antigens in an Egyptian rural area. J Trop Pediatr 1996;42:154-7.
60. Granstrom M, Leinikki P, Santavuori P, et al. Perinatal cytomegalovirus infection in man. Arch Dis Child 1977;52: 354-9.
61. Minamishima I, Ueda K, Minematsu T, et al. Role of breast milk in acquisition of cytomegalovirus infection. Microbiol Immunol 1994;38:549-52.
62. Numazaki K. Human cytomegalovirus infection of breast milk. FEMS Immunol Med Microbiol 1997;18:91-8.
63. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA 1986;256:1904-8.
64. Vial P, Torres-Pereyra J, Stagno S, et al. Serologic screening for cytomegalovirus, rubella virus, herpes simplex virus, hepatitis B virus, and Toxoplasma gondii in two urban populations of pregnant women in Chile. Bull Pan Am Health Organ 1986;20:53-61.
65. Hirota K, Muraguchi K, Watabe N, et al. Prospective study on maternal, intrauterine, and perinatal infections with cytomegalovirus in Japan during 1976-1990. J Med Virol 1992; 37:303-6.
66. Fowler KB, Stagno S, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 1993;168:552-6.
67. Stagno S, Pass RF, Dworsky ME, et al. Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med 1982;306:945-9.
68. Sohn YM, Oh MK, Balcarek KB, et al. Cytomegalovirus infection in sexually active adolescents. J Infect Dis 1991; 163:460-3.
69. Chandler SH, Alexander ER, Holmes KK. Epidemiology of cytomegaloviral infection in a heterogeneous population of pregnant women. J Infect Dis 1985;152:249-56.
70. Pass RF, Hutto C. Group day care and cytomegaloviral infections of mothers and children. Rev Infect Dis 1986;8: 599-605.
71. Adler SP, Baggett J, Wilson M, et al. Molecular epidemiology of cytomegalovirus in a nursery: lack of evidence for nosocomial transmission. J Pediatr 1986;108:117-23.
72. Bale JF Jr, Zimmerman B, Dawson JD, et al. Cytomegalovirus transmission in child care homes. Arch Pediatr Adolesc Med 1999;153:75-9.
73. Preece PM, Tookey P, Ades A, et al. Congenital cytomegalovirus infection: predisposing maternal factors. J Epidemiol Community Health 1986;40:205-9.
74. Nigro G, La Torre R, Mazzocco M, et al. Multi-system cytomegalovirus fetopathy by recurrent infection in a pregnant woman with hepatitis B. Prenat Diagn 1999;19:1070-2.
75. Schwebke K, Henry K, Balfour HH Jr, et al. Congenital cytomegalovirus infection as a result of nonprimary cytomegalovirus disease in a mother with acquired immunodeficiency syndrome. J Pediatr 1995;126:293-5.
76. Mussi-Pinhata MM, Yamamoto AY, Figueiredo LT, et al. Congenital and perinatal cytomegalovirus infection in infants born to mothers infected with human immunodeficiency virus. J Pediatr 1998;132:285-90.
77. Fowler KB, Pass RF. Sexually transmitted diseases in mothers of neonates with congenital cytomegalovirus infection. J Infect Dis 1991;164:259-64.
78. Blau EB, Gross JR. Congenital cytomegalovirus infection after recurrent infection in a mother with a renal transplant. Pediatr Nephrol 1997;11:361-2.
79. Laifer SA, Ehrlich GD, Huff DS, et al. Congenital cytomegalovirus infection in offspring of liver transplant recipients. Clin Infect Dis 1995;20:52-5.
80. vans TJ, McCollum JP, Valdimarsson H. Congenital cytomegalovirus infection after maternal renal transplantation. Lancet 1975;1:1359-60.
81. McGregor JA, Rubright G, Ogle JW. Congenital cytomegalovirus infection as a preventable complication of maternal transfusion: a case report. J Reprod Med 1990;35:61-4.
82. King-Lewis PA, Gardner SD. Congenital cytomegalic inclusion disease following intrauterine transfusion. Br Med J 1969;2:603-5.
83. Murph JR, Souza IE, Dawson JD, et al. Epidemiology of congenital cytomegalovirus infection: maternal risk factors and molecular analysis of cytomegalovirus strains. Am J Epidemiol 1998;147:940-7.
84. Balcarek KB, Bagley R, Cloud GA, et al. Cytomegalovirus infection among employees of a children's hospital: no evidence for increased risk associated with patient care. JAMA 1990;263:840-4.
85. Pass RF, Hutto C, Lyon MD, et al. Increased rate of cytomegalovirus infection among day care center workers. Pediatr Infect Dis J 1990;9:465-70.
86. Ahlfors K, Ivarsson SA, Johnsson T, et al. Primary and secondary maternal cytomegalovirus infections and their relation to congenital infection: analysis of maternal sera. Acta Paediatr Scand 1982;71:109-13.
87. McCracken GH Jr, Shinefield HM, Cobb K, et al. Congenital cytomegalic inclusion disease: a longitudinal study of 20 patients. Am J Dis Child 1969;117:522-39.
88. Berenberg W, Nankervis G. Long-term follow-up of cytomegalic inclusion disease of infancy. Pediatrics 1970;46: 403-10.
89. Stagno S, Reynolds DW, Lakeman A, et al. Congenital cytomegalovirus infection: consecutive occurrence due to viruses with similar antigenic compositions. Pediatrics 1973; 52:788-94.
90. Nigro G, Clerico A, Mondaini C. Symptomatic congenital cytomegalovirus infection in two consecutive sisters. Arch Dis Child 1993;69:527-8.
91. Huang ES, Alford CA, Reynolds DW, Stagno S, Pass RF. Molecular epidemiology of cytomegalovirus infections in women and their infants. N Engl J Med 1980;303:958-62.
92. Witters I, Van Ranst M, Fryns JP. Cytomegalovirus reactivation in pregnancy and subsequent isolated bilateral hearing loss in the infant. Genet Couns 2000;11:375-8.
93. Ahlfors K, Forsgren M, Ivarsson SA, et al. Congenital cytomegalovirus infection: on the relation between type and time of maternal infection and infant's symptoms. Scand J Infect Dis 1983;15:129-38.
94. Ahlfors K, Ivarsson SA, Harris S. Secondary maternal cytomegalovirus infection: a significant cause of congenital disease. Pediatrics 2001;107:1227-8.
95. Inoue T, Matsumura N, Fukuoka M, et al. Severe congenital cytomegalovirus infection with fetal hydrops in a cytomegalovirus-seropositive healthy woman. Eur J Obstet Gynecol Reprod Biol 2001;95:184-6.
96. Boppana SB, Fowler KB, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999;104:55-60.
97. Portolani M, Cermelli C, Sabbatini AM, et al. A fatal case of congenital cytomegalic inclusion disease following recurrent maternal infection. N Microbiol 1995;18:427-8.
98. Morris DJ, Sims D, Chiswick M, et al. Symptomatic congenital cytomegalovirus infection after maternal recurrent infection. Pediatr Infect Dis J 1994;13:61-4.
99. Rutter D, Griffiths P, Trompeter RS. Cytomegalic inclusion disease after recurrent maternal infection. Lancet 1985;2: 1182.
100. Ahlfors K, Harris S, Ivarsson S, et al. Secondary maternal cytomegalovirus infection causing symptomatic congenital infection. N Engl J Med 1981;305:284.
101. Grant S, Edmond E, Syme J. A prospective study of cytomegalovirus infection in pregnancy, I: laboratory evidence of congenital infection following maternal primary and reactivated infection. J Infect 1981;3:24-31.
102. Boppana SB, Rivera LB, Fowler KB, et al. Intrauterine transmission of cytomegalovirus to infants of women with preconceptional immunity. N Engl J Med 2001;344:1366-71.
103. Harrison CJ, Myers MG. Relation of maternal CMV viremia and antibody response to the rate of congenital infection and intrauterine growth retardation. J Med Virol 1990;31:222-8.
104. Steinlin MI, Nadal D, Eich GF, et al. Late intrauterine Cytomegalovirus infection: clinical and neuroimaging findings. Pediatr Neurol 1996;15:249-53.
105. Fowler KB, Stagno S, Pass RF, et al. The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med 1992;326:663-7.
106. Preece PM, Blount JM, Glover J, et al. The consequences of primary cytomegalovirus infection in pregnancy. Arch Dis Child 1983;58:970-5.
107. Ahlfors K, Ivarsson SA, Nilsson H. On the unpredictable development of congenital cytomegalovirus infection: a study in twins. Early Hum Dev 1988;18:125-35.
108. Seguin J, Cho CT. Congenital cytomegalovirus infection in one monozygotic twin. JAMA 1988;260:3277.
109. Duvekot JJ, Theewes BA, Wesdorp JM, et al. Congenital cytomegalovirus infection in a twin pregnancy: a case report. Eur J Pediatr 1990;149:261-2.
110. Vogler C, Kohl S, Rosenberg HS. Cytomegalovirus infection and fetal death in a twin. A case report. J Reprod Med 1986;31:207-10.
111. Schneeberger PM, Groenendaal F, de Vries LS, et al. Variable outcome of a congenital cytomegalovirus infection in a quadruplet after primary infection of the mother during pregnancy. Acta Paediatr 1994;83:986-9.
112. Saigal S, Eisele WA, Chernesky MA. Congenital cytomegalovirus infection in a pair of dizygotic twins. Am J Dis Child 1982;136:1094-5.
113. Boppana SB, Pass RF, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J 1992;11:93-9.
114. Bale JF Jr, Blackman JA, Sato Y. Outcome in children with symptomatic congenital cytomegalovirus infection. J Child Neurol 1990;5:131-6.
115. Hardy JB, Sever JL. Indirect inguinal hernia in congenital rubella. J Pediatr 1968;73:416-8.
116. Hanshaw JB. Congenital cytomegalovirus infection: a fifteen year perspective. J Infect Dis 1971;123:555-61.
117. Stagno S, Pass RF, Thomas JP, et al. Defects of tooth structure in congenital cytomegalovirus infection. Pediatrics 1982;69:646-8.
118. Reiterer F, Dornbusch HJ, Urlesberger B, et al. Cytomegalovirus associated neonatal pneumonia and Wilson-Mikity syndrome: a causal relationship? Eur Respir J 1999;13: 460-2.
119. Ng PC, Fok TF, Lee CH, et al. Congenital cytomegalovirus infection presenting as severe persistent pulmonary hypertension of the newborn. J Perinatol 1998;18:234-7.
120. Morton R. Congenital cytomegalovirus infection presenting as massive ascites with secondary pulmonary hypoplasia. Hum Pathol 1986;17:760.
121. Carrol ED, Campbell ME, Shaw BN, et al. Congenital lobar emphysema in congenital cytomegalovirus infection. Pediatr Radiol 1996;26:900-2.
122. Ivarsson SA, Bjerre I, Vegfors P, et al. Autism as one of several disabilities in two children with congenital cytomegalovirus infection. Neuropediatrics 1990;21:102-3.
123. Weinstein M, Ford-Jones E, Cutz E. Esophagatis and perinatal cytomegalovirus infection. Pediatr Infect Dis J 2001; 20:545-6.
124. Reyes C, Pereira S, Warden MJ, et al. Cytomegalovirus enteritis in a premature infant. J Pediatr Surg 1997;32: 1545-7.
125. Huang YC, Lin TY, Huang CS, et al. Ileal perforation caused by congenital or perinatal cytomegalovirus infection. J Pediatr 1996;129:931-4.
126. Caksen H, Odabas D, Anlar O. Congenital cytomegalovirus infection associated with finger anomaly. J Paediatr Child Health 2002;38:105.
127. Fraser SH, O'Keefe RJ, Scurry JP, et al. Hydrocephalus ex vacuo and clasp thumb deformity due to congenital cytomegalovirus infection. J Paediatr Child Health 1994;30:450-2.
128. Lanari M, Lazzarotto T, Papa I, et al. Neonatal aortic arch thrombosis as a result of congenital cytomegalovirus infection. Pediatrics 2001;108:E114.
129. Kubo S, Kishino T, Satake N, et al. A neonatal case of hydranencephaly caused by atheromatous plaque obstruction of aortic arch: possible association with a congenital cytomegalovirus infection? J Perinatol 1994;14:483-6.
130. Iwasaki T, Monma N, Satodate R, et al. Myocardial lesions by Coxsackie virus B3 and cytomegalovirus infection in infants. Heart Vessels Suppl 1985;1:167-72.
131. Karn K, Julian TM, Ogburn PL Jr. Fetal heart block associated with congenital cytomegalovirus infection: a case report. J Reprod Med 1984;29:278-80.
132. Campbell PT, Li JS, Wall TC, et al. Cytomegalovirus pericarditis: a case series and review of the literature. Am J Med Sci 1995;309:229-34.
133. Salisbury S, Embil JA. Graves disease following congenital cytomegalovirus infection. J Pediatr 1978;92:954-5.
134. Mena W, Royal S, Pass RF, et al. Diabetes insipidus associated with symptomatic congenital cytomegalovirus infection. J Pediatr 1993;122:911-3.
135. Ivarsson SA, Lindberg B, Nilsson KO, et al. The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabet Med 1993;I:10 521-3.
136. Jenson HB, Robert MF. Congenital cytomegalovirus infection with osteolytic lesions: use of DNA hybridization in diagnosis. Clin Pediatr (Phila) 1987;26:448-52.
137. Smith RK, Specht EE. Osseous lesions and pathologic fractures in congenital cytomegalic inclusion disease: report of a case. Clin Orthop 1979;144:280-3.
138. McCandless AE, Davis C, Hall EG. Bone changes in congenital cytomegalic inclusion disease. Arch Dis Child 1975;50:160-3.
139. Kopelman AE, Minnefor AB, Halsted CC. Osteomalacia and spontaneous fractures in twins with congenital cytomegalic inclusion disease. J Pediatr 1972;81:101-5.
140. Ivarsson SA, Ljung R. Neutropenia and congenital cytomegalovirus infection. Pediatr Infect Dis J 1988;7:436-7.
141. Chesney PJ, Taher A, Gilbert EM, et al. Intranuclear inclusions in megakaryocytes in congenital cytomegalovirus infection. J Pediatr 1978;92:957-8.
142. Batisky DL, Roy S III, Gaber LW. Congenital nephrosis and neonatal cytomegalovirus infection: a clinical association. Pediatr Nephrol 1993;7:741-3.
143. Dandge VP, Dharnidharka VR, Dalwai W, et al. Congenital mesangioproliferative nephrotic syndrome associated with cytomegalovirus infection. Indian Pediatr 1993;30:665-7.
144. Beneck D, Greco MA, Feiner HD. Glomerulonephritis in congenital cytomegalic inclusion disease. Hum Pathol 1986; 10:1054-9.
145. Blatt J, Kastner O, Hodes DS. Cutanenous vesicles in congenital cytomegalovirus infection. J Pediatr 1978;92: 509.
146. Blatt J, Kastner O, Hodes DS. Cutanenous vesicles in congenital cytomegalovirus infection. J Pediatr 1978;92:509.
147. Purvis-Smith SG, Hayes K, Menser MA. Dermatoglyphics in children with prenatal cytomegalovirus infection. Lancet 1972;2:976-7.
148. Boppana SB, Fowler KB, Vaid Y, et al. Neuroradiographic findings in the newborn period and long-term outcome in children with symptomatic congenital cytomegalovirus infection. Pediatrics 1997;99:409-14.
149. Sugita K, Ando M, Makino M, et al. Magnetic resonance imaging of the brain in congenital rubella virus and cytomegalovirus infections. Neuroradiology 1991;33:239-42.
150. Toma P, Magnano GM, Mezzano P, et al. Cerebral ultrasound images in prenatal cytomegalovirus infection. Neuroradiology 1989;31:278-9.
151. Noyola DE, Demmler GJ, Nelson CT, et al. Early predictors of neurodevelopmental outcome in symptomatic congenital cytomegalovirus infection. J Pediatr 2001;138:325-31.
152. Dahle AJ, Fowler KB, Wright JD, et al. Longitudinal investigation of hearing disorders in children with congenital cytomegalovirus. J Am Acad Audiol 2000;11:283-90.
153. Williamson WD, Demmler GJ, Percy AK, et al. Progressive hearing loss in infants with asymptomatic congenital cytomegalovirus infection. Pediatrics 1992;90:862-6.
154. Boppana S, Amos C, Britt W, et al. Late onset and reactivation of chorioretinitis in children with congenital cytomegalovirus infection. Pediatr Infect Dis J 1994;13:1139-42.
155. Hanshaw JB, Scheiner AP, Moxley AW, et al. School failure and deafness after "silent" congenital cytomegalovirus infection. N Engl J Med 1976;295:468-70.
156. Williamson WD, Percy AK, Yow MD, et al. Asymptomatic congenital cytomegalovirus infection: audiologic, neuroradiologic, and neurodevelopmental abnormalities during the first year. Am J Dis Child 1990;144:1365-8.
157. Kumar ML, Nankervis GA, Jacobs IB, et al. Congenital and postnatally acquired cytomegalovirus infections: long-term follow-up. J Pediatr 1984;104:674-9.
158. Conboy TJ, Pass RF, Stagno S, et al. Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics 1986;77:801-6.
159. Kashden J, Frison S, Fowler K, et al. Intellectual assessment of children with asymptomatic congenital cytomegalovirus infection. J Dev Behav Pediatr 1998;19:254-9.
160. Temple RO, Pass RF, Boll TJ. Neuropsychological functioning in patients with asymptomatic congenital cytomegalovirus infection. J Dev Behav Pediatr 2000;21:417-22.
161. Fowler KB, Dahle AJ, Boppana SB, et al. Newborn hearing screening: will children with hearing loss caused by congenital cytomegalovirus infection be missed? J Pediatr 1999; 135:60-4.
162. Ivarsson SA, Lernmark B, Svanberg L. Ten-year clinical, developmental, and intellectual follow-up of children with congenital cytomegalovirus infection without neurologic symptoms at one year of age. Pediatrics 1997;99:800-3.
163. Anderson KS, Amos CS, Boppana S, et al. Ocular abnormalities in congenital cytomegalovirus infection. J Am Optom Assoc 1996;67:273-8.
164. Coats DK, Demmler GJ, Paysse EA, et al. Ophthalmologic findings in children with congenital cytomegalovirus infection. J AAPOS 2000;4:110-6.
165. Byrne PJ, Silver MM, Gilbert JM, et al. Cyclopia and congenital cytomegalovirus infection. Am J Med Genet 1987;28:61-5.
166. Stago S, Reynolds DW, Amos CS, et al. Auditory and visual defects resulting from symptomatic and subclinical congenital cytomegaloviral and toxoplasma infections. Pediatrics 1977;59:669-78.
167. Noyola DE, Demmler GJ, Williamson WD, et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection: Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J 2000;19:505-10.
168. Rawlinson WD. Broadsheet. Number 50: Diagnosis of human cytomegalovirus infection and disease. Pathology 1999; 31:109-15.
169. Lazzarotto T, Varani S, Spezzacatena P, et al. Maternal IgG avidity and IgM detected by blot as diagnostic tools to identify pregnant women at risk of transmitting cytomegalovirus. Viral Immunol 2000;13:137-41.
170. Enders G, Bader U, Lindemann L, et al. Prenatal diagnosis of congenital cytomegalovirus infection in 189 pregnancies with known outcome. Prenat Diagn 2001;21:362-77.
171. Gouarin S, Palmer P, Cointe D, et al. Congenital HCMV infection: a collaborative and comparative study of virus detection in amniotic fluid by culture and by PCR. J Clin Virol 2001;21:47-55.
172. Lazzarotto T, Varani S, Guerra B, et al. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000;137: 90-5.
173. Revello MG, Zavattoni M, Baldanti F, et al. Diagnostic and prognostic value of human cytomegalovirus load and IgM antibody in blood of congenitally infected newborns. J Clin Virol 1999;14:57-66.
174. Yamamoto AY, Mussi-Pinhata MM, Pinto PC, et al. Usefulness of blood and urine samples collected on filter paper in detecting cytomegalovirus by the polymerase chain reaction technique. J Virol Methods 2001;97:159-64.
175. Barbi M, Binda S, Primache V, et al. Cytomegalovirus DNA detection in Guthrie cards: a powerful tool for diagnosing congenital infection. J Clin Virol 2000;17:159-65.
176. Johansson PJ, Jonsson M, Ahlfors K, et al. Retrospective diagnostics of congenital cytomegalovirus infection performed by polymerase chain reaction in blood stored on filter paper. Scand J Infect Dis 1997;29:465-8.
177. Nelson CT, Istas AS, Wilkerson MK, et al. PCR detection of cytomegalovirus DNA in serum as a diagnostic test for congenital cytomegalovirus infection. J Clin Microbiol 1995; 33:3317-8.
178. Kearns AM, Turner AJ, Eltringham GJ, et al. Rapid detection and quantification of CMV DNA in urine using LightCycler-based real-time PCR. J Clin Virol 2002;24:131-4.
179. Kohyama J, Kajiwara M, Shimohira M, et al. Human cytomegalovirus DNA in cerebrospinal fluid. Arch Dis Child 1994;71:414-8.
180. Casteels A, Naessens A, Gordts F, et al. Neonatal screening for congenital cytomegalovirus infections. J Perinat Med 1999;27:116-21.
181. Panhani S, Heinonen KM. Screening for congenital cytomegalovirus infection among preterm infants born before the 34th gestational week in Finland. Scand J Infect Dis 1994; 26:375-8.
182. Peckham C, Tookey P, Logan S, et al. Screening options for prevention of congenital cytomegalovirus infection. J Med Screen 2001;8:119-24.
183. Nigro G, Scholz H, Bartmann U. Ganciclovir therapy for symptomatic congenital cytomegalovirus infection in infants: a two-regimen experience. J Pediatr 1994;124:318-22.
184. Nigro G, Krzysztofiak A, Bartmann U, et al. Ganciclovir therapy for cytomegalovirus-associated liver disease in immunocompetent or immunocompromised children. Arch Virol 1997;142:573-80.
185. Fukuda S, Miyachi M, Sugimoto S, et al. A female infant successfully treated by ganciclovir for congenital cytomegalovirus infection. Acta Paediatr Jpn 1995;37:206-10.
186. Stronati M, Revello MG, Cerbo RM, et al. Ganciclovir therapy of congenital human cytomegalovirus hepatitis. Acta Paediatr 1995;84:340-1.
187. Vallejo JG, Englund JA, Garcia-Prats JA, et al. Ganciclovir treatment of steroid-associated cytomegalovirus disease in a congenitally infected neonate. Pediatr Infect Dis J 1994;13: 239-41.
188. Reigstad H, Bjerknes R, Markestad T, et al. Ganciclovir therapy of congenital cytomegalovirus disease. Acta Paediatr 1992;81:707-8.
189. Hocker JR, Cook LN, Adams G, et al. Ganciclovir therapy of congenital cytomegalovirus pneumonia. Pediatr Infect Dis J 1990;9:743-5.
190. Zhou XJ, Gruber W, Demmler G, et al. Population pharmacokinetic of ganciclovir in newborns with congenital cytomegalovirus infections: NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother 1996;40: 2202-5.
191. Trang JM, Kidd L, Gruber W, et al. Linear single-dose pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections: NIAID Collaborative Antiviral Study Group. Clin Pharmacol Ther 1993;53:15-21.
192. Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis 1997;175:1080-6.
193. Lagasse N, Dhooge I, Govaert P. Congenital CMV-infection and hearing loss. Acta Otorhinolaryngol Belg 2000;54: 431-6.
194. Chatterjee A, Harrison CJ, Britt WJ, et al. Modification of maternal and congenital cytomegalovirus infection by antiglycoprotein b antibody transfer in guinea pigs. J Infect Dis 2001;183:1547-53.
195. Negishi H, Yamada H, Hirayama E, et al. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J Perinatol 1998;18: 466-9.
196. Riddell SR, Greenberg PD. T-cell therapy of cytomegalovirus and human immunodeficiency virus infection. J Antimicrob Chemother 2000;45(Suppl T3):35-43.
197. Plotkin SA. Cytomegalovirus vaccine. Am Heart J 1999;138: S484-7.
198. Bourne N, Schleiss MR, Bravo FJ, et al. Preconception immunization with a cytomegalovirus (CMV) glycoprotein vaccine improves pregnancy outcome in a guinea pig model of congenital CMV infection. J Infect Dis 2001;183:59-64.
199. Bernstein DI, Schleiss MR, Berencsi K, et al. Effect of previous or simultaneous immunization with canarypox expressing cytomegalovirus (CMV) glycoprotein B (gB) on response to subunit gB vaccine plus MF59 in healthy CMV-seronegative adults. J Infect Dis 2002;185:686-90.
200. Porath A, McNutt RA, Smiley LM, et al. Effectiveness and cost benefit of a proposed live cytomegalovirus vaccine in the prevention of congenital disease. Rev Infect Dis 1990; 12:31-40.